PROCEEDS AGREEMENTProceeds Agreement • May 9th, 2024 • Baker Bros. Advisors Lp • Services-commercial physical & biological research
WHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 15,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;
Loan Agreement Between 667, L.P and Baker Bros. Advisors LPLoan Agreement • May 9th, 2024 • Baker Bros. Advisors Lp • Services-commercial physical & biological research • New York
For value received, Baker Bros. Advisors LP (the “Management Company”) promises to pay 667, L.P. (“667”), the amounts set forth in Schedule A below, payable on the Due Date (as defined below) with interest payable through the Due Date (as defined below) at a rate of 4.55% annually.
